Androgens and the control of skeletal muscle protein synthesis

Annals of Medicine

Volumn 32, Issue 3, 2000, Pages 181-186

  Sheffield Moore, Melinda ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

Androgen receptors; Androgens; Protein synthesis; Skeletal muscle mass

Indexed keywords

ANABOLIC AGENT; ANDROGEN; ANDROGEN RECEPTOR; MUSCLE PROTEIN;

HUMAN; LEAN BODY WEIGHT; MUSCLE MASS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; SKELETAL MUSCLE;

EID: 0034012929     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853890008998825     Document Type: Review

References (54)

1. Biolo G, Chinkes D, Zhang X, Wolfe RR. A new model to determine in vivo the relationship between amino acid transmembrane transport and protein kinetics in muscle. J Parenter Enteral Nutr 1992; 16: 305-15.
2. Wolfe RR. Radioactive and stable isotope tracers in biomedicine: principles and practices in kinetic analysis. New York, NY: Wiley-Liss; 1992.
3. Trapman J, Klanssen P, Kuiper GGJM, van der Korput JAGM, Faber PW, van Rooij HCJ, et al. Cloning, structure and expression of a cDNA encoding the human androgen receptor. Biochem Biophys Res Commun 1988; 153: 241-8.
4. Tilley WD, Marcelli M, Wilson JD, McPhaul MJ. Characterization and expression of a cDNA encoding the human androgen receptor. Proc Natl Acad Sci U S A 1989; 86: 327-31.
5. Lubahn DB, Joseph DR, Sullivan PM, Willard HF, French FS, Wilson EM. Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 1988; 240: 327-30.
6. Chang C, Kokontis J, Liao S. Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 1988; 240: 324-6.
7. Siiteri PK, MacDonald PC. Role of extraglandular estrogen in human endocrinology. In: Greep RO, Astwood EB, eds. Handbook of physiology II, section 7, endocrinology. Washington, DC: American Physiological Society; 1973: 615-29.
8. Wilson JD, Aiman J, MacDonald PC. The pathogenesis of gynecomastia. Adv Intern Med 1980; 25: 1-32.
9. Moore RJ, Gazak JM, Wilson JD. Regulation of cytoplasmic dihydrotestosterone binding in dog prostate by 17B-estradiol. J Clin Invest 1979; 63: 351-7.
10. Griffin JE, Wilson JD. Disorders of the testes and the male reproductive tract. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds. Williams textbook of endocrinology. Philadelphia, PA: WB Saunders; 1998: 819-75.
11. Griggs RC, Kingston W, Jozefowicz RF, Herr BE, Forbes G, Halliday D. Effect of testosterone on muscle mass and muscle protein synthesis. J Appl Physiol 1989; 66: 498-503.
12. Ferrando AA, Tipton KD, Doyle D, Phillips SM, Cortiella J, Wolfe RR. Testosterone injection stimulates net protein synthesis but not tissue amino acid transport. Am J Physiol 1998; 275: E864-71.
13. Sheffield-Moore M, Urban RJ, Wolf SE, Jiang J, Catlin DH, Herndon DN, et al. Short term oxandrolone administration stimulates net muscle protein synthesis in young men. J Clin Endocrinol Metab 1999; 84: 2705-11.
14. Brodsky IG, Balagopal P, Nair KS. Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men - a clinical research center study. J Clin Endocrinol Metab 1996; 81: 3469-75.
15. Katznelson L, Kinkelstein JS, Schoenfeld DA, Rosenthal DI, Anderson EJ, Klibanski A. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab 1996; 81: 4358-65.
16. Bhasin S, Storer TW, Berman N, Yarasheski KE, Clevenger B, Phillips J, et al. Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab 1997; 82: 407-13.
17. Tenover JS. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 1992; 75: 1092-8.
18. Urban RJ, Bodenburg C, Gilkison C, Foxworth J, Coggan AR, Wolfe RR, et al. Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol 1995; 269: E820-6.
19. Grinspoon S, Corcoran C, Lee K, Burrows B, Hubbard J, Katznelson L, et al. Loss of lean body mass and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting. J Clin Endocrinol Metab 1996; 81: 4051-8.
20. Kimura N, Mizokami A, Oonuma T, Sasano H, Nagura H. Immunocytochemical localization of androgen receptor with polyclonal antibody in parrafin-embedded human tissues. J Histochem Cytochem 1993; 41: 671-8.
21. Chang C, Kokontis J, Liao S. Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proc Natl Acad Sci U S A 1988; 85: 7211-5.
22. Wilson JD, Gloyna E. The intranuclear metabolism of testosterone in the accessory organs of male reproduction. Rec Prog Horm Res 1970; 26: 309-36.
23. Brinkman AO, Blok LJ, de Ruiter PE, Doesberg P, Steketee K, Berrevoets CA, et al. Mechanisms of androgen receptor activation and function. J Steroid Biochem Mol Biol 1999; 69: 307-13.
24. Inoue K, Yamasaki S, Fushiki T, Okada Y, Sugimoto E. Androgen receptor antagonist suppresses exercise-induced hypertrophy of skeletal muscle. Eur J Appl Physiol 1994; 69: 88-91.
25. Verhoeven G, Swinnen JV. Indirect mechanisms and cascades of androgen action. Mol Cell Endocrinol 1999; 151: 205-12.
26. Arnold AM, Peralta JM, Thonney ML. Ontogeny of growth hormone, insulin-like growth factor-I, estrodiol and cortisol in the growing lamb: effect of testosterone. J Endocrinol 1996; 150: 391-9.
27. Mauras N, Hayes V, Welch S, Rini A, Helgeson K, Dokler M, et al. Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity. J Clin Endocrinol Metab 1998; 83: 1886-92.
28. Hayes V, Jiang J, Urban RJ, Mauras N. IGF-I and androgenic steroids: synergistic effects in man. Proceedings from the 81st Annual Meeting of the Endocrine Society; 1999 June 12-15; San Diego, CA. The Endocrine Society Press; 1999: 571.
29. Doumit ME, Cook DR, Merkel RA. Testosterone up-regulates androgen receptors and decreases differentiation of porcine myogenic satellite cells in vitro. Endocrinology 1996; 137: 1385-94.
30. Fryburg DA. Insulin-like growth factor I exerts growth hormone- and insulin-like actions on human muscle protein metabolism. Am J Physiol 1994; 267: E331-6.
31. Wolfe R, Ferrando A, Sheffield-Moore M, Urban R. Testosterone and muscle protein metabolism. Mayo Clin Proc 2000; 15 (Suppl): S55-60.
32. Hickson RC, Czerwinski SM, Falduto MT, Young AP. Glucocorticoid antagonism by exercise and androgenic-anabolic steroids. Med Sci Sports Exerc 1990; 22: 331-40.
33. Misrahi M, Atger M, d'Auriol L, Loosfelt H, Meriel C, Frindlansky F, et al. Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA. Biochem Biophys Res Commun 1987; 143: 740-8.
34. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, et al. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 1987; 237: 268-75.
35. Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, et al. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 1985; 318: 635-41.
36. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, et al. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 1986; 320: 134-9.
37. Danhaive PA, Rousseau GG. Binding of glucocorticoid antagonists to androgen and glucocorticoid hormone receptors in rat skeletal muscle. J Steroid Biochem Mol Biol 1986; 24: 481-7.
38. Danhaive PA, Rousseau GG. Evidence for sex-dependent anabolic response to androgenic steroids mediated by muscle glucocorticoid receptors in the rat. J Steroid Biochem Mol Biol 1988; 29: 575-81.
39. Wu FCW. Endocrine aspects of anabolic steroids. Clin Chem 1997; 43: 1289-92.
40. Woolf PD. Hormonal responses to trauma. Crit Care Med 1992; 20: 216-26.
41. Vaughn GM, Becker RA, Allen JP, Goodwin CW Jr, Pruitt BA Jr, Mason AD Jr. Cortisol and corticotropin in burned patients. J Trauma 1982; 22: 263-73.
42. Ferrando AA, Sheffield-Moore M, Wolf SE, Herndon DN, Wolfe RR. Testosterone normalization in severe burns ameliorates muscle catabolism. J FASEB 2000; 14: 4, A 797.
43. McPherron AC, Lawler AM, Lee S-J. Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci U S A 1997; 94: 12457-61.
44. Grobet L, Martin LJR, Poncelet D, Pirottin D, Brouwers B, Riquet J, et al. A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet 1997; 17: 71-4.
45. McPherron AC, Lawler AM, Lee S-J. Regulation of skeletal muscle mass in mice by a new TGF-B superfamily member. Nature 1997; 387: 83-90.
46. Gonzales-Cadavid NF, Taylor WE, Yarasheski KE, Sinha-Hikim I, Ma K, Ezzat S, et al. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc Natl Acad Sci U S A 1998; 95: 14938-43.
47. Sussman MA, Lim HW, Gude N, Taigen T, Olson EN, Robbins J, et al. Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science 1998; 281: 1690-3.
48. Molkentin JD, Lu J-R, Antos CL, Markham B, Richardson J, Robbins J, et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998; 93: 215-28.
49. Dunn SE, Burns JL, Michel RN. Calcineurin is required for skeletal muscle hypertrophy. J Biol Chem 1999; 274: 21908-12.
50. Barton-Davis E, Shoturma DL, Musaro A, Rosenthal N, Sweeney HL. Viral mediated expression of IGF-1 blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci U S A 1998; 95: 15603.
51. Musaro A, McCullagh KJA, Naya FJ, Olson EN, Rosenthal N. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATcl. Nature 1999; 400: 581-5.
52. Negro-Vilar A. Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium. J Clin Endocrinol Metab 1999; 84: 3459-62.
53. 8,9 dehydroestrone sulfate in postmenopausal women. J Clin Endocrinol Metab 1999; 84: 2020-7.
54. Cosman F, Lindsay R. Selective estrogen receptor modulators: clinical spectrum. Endocr Rev 1999; 20: 418-34.